Global Information
회사소개 | 문의 | 위시리스트

연속 혈당 측정(CGM) 시스템/장치 시장 규모, 점유율, 동향 분석 : 컴포넌트별(송신기, 센서, 인슐린 펌프), 최종 용도별(병원, 자택치료), 부문 예측(2018-2024년)

Continuous Glucose Monitoring (CGM) Systems/Devices Market Size, Share & Trends Analysis Report By Component (Transmitters, Sensors, Insulin Pumps), By End Use (Hospitals, Homecare), And Segment Forecasts, 2018 - 2024

리서치사 Grand View Research, Inc.
발행일 2018년 07월 상품 코드 682154
페이지 정보 영문 55 Pages
가격
US $ 5,950 ₩ 7,323,000 Unprintable PDF by E-mail (Single User License)
US $ 6,950 ₩ 8,554,000 Printable PDF by E-mail (5-User License)
US $ 8,950 ₩ 11,015,000 Printable PDF by E-mail (Enterprise License)


연속 혈당 측정(CGM) 시스템/장치 시장 규모, 점유율, 동향 분석 : 컴포넌트별(송신기, 센서, 인슐린 펌프), 최종 용도별(병원, 자택치료), 부문 예측(2018-2024년) Continuous Glucose Monitoring (CGM) Systems/Devices Market Size, Share & Trends Analysis Report By Component (Transmitters, Sensors, Insulin Pumps), By End Use (Hospitals, Homecare), And Segment Forecasts, 2018 - 2024
발행일 : 2018년 07월 페이지 정보 : 영문 55 Pages

세계의 연속 혈당 측정(CGM) 시스템/장치 시장 규모는 2024년까지 10억 1,000만 달러에 이를 것으로 예측됩니다. 당뇨병 증가, 신규 및 최신 당뇨병 케어 장치 도입 등이 시장 성장을 촉진하는 주요인입니다.

세계의 연속 혈당 측정(CGM: Continuous Glucose Monitoring) 시스템/장치 시장을 조사했으며, 시장 현황과 2024년까지 성장 예측, 컴포넌트별·최종 용도별·지역별 동향, 시장 진출기업 개요 등을 정리하여 전해드립니다.

제1장 조사 방법과 범위

제2장 주요 요약

제3장 업계 전망

  • 시장 세분화
  • 시장 규모와 성장 전망
  • 시장 동향
    • 시장 성장 촉진요인 분석
    • 시장 성장 저해요인 분석
  • 업계 동향 분석
  • PESTLE 분석
  • Porter's Five Forces 모델
  • 기업의 시장 점유율 분석
  • 우선시되는 주요 기회

제4장 마케팅 제품별 전망

  • 매출 점유율 : 제품별
  • 송신기와 수신기
  • 센서
  • 인슐린 펌프

제5장 최종사용자별 전망

  • 매출 점유율 : 최종사용자별
  • 병원
  • 자택치료/진단
  • 기타

제6장 지역별 전망

  • 시장 점유율 : 지역별
  • 북미
  • 유럽
  • 아시아태평양
  • 중동 및 아프리카
  • 라틴아메리카

제7장 경쟁 환경

  • Roche Diagnostics
  • Dexcom Inc.
  • Abbott Laboratories
  • Medtronic Inc.
  • Animas Corporation
  • Novo Nordisk
  • Ypsomed AG
  • GlySens Incorporated
LSH 18.09.05

List of Tables

  • 1. Continuous Glucose Monitoring Devices - Industry Snapshot & Key Buying Criteria, 2013 - 2024
  • 2. Continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 3. Continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 4. Continuous glucose monitoring devices market, by region, 2013 - 2024 (USD Million)
  • 5. Continuous glucose monitoring devices - Key Market Driver Analysis
  • 6. Continuous glucose monitoring devices - Key Market Restraint Analysis
  • 7. North America continuous glucose monitoring devices market revenue, 2013 - 2024 (USD Million)
  • 8. U.S. continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 9. U.S. continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 10. Canada continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 11. Canada continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 12. Europe continuous glucose monitoring devices market revenue, 2013 - 2024 (USD Million)
  • 13. Germany continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 14. Germany continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 15. U.K. continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 16. U.K. continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 17. Asia Pacific continuous glucose monitoring devices market revenue, 2013 - 2024 (USD Million)
  • 18. China continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 19. China continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 20. India continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 21. India continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 22. Latin America continuous glucose monitoring devices market revenue, 2013 - 2024 (USD Million)
  • 23. Brazil continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 24. Brazil continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 25. Mexico continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 26. Mexico continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 27. MEA continuous glucose monitoring devices market revenue, 2013 - 2024 (USD Million)
  • 28. South Africa continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 29. South Africa continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)
  • 30. Saudi Arabia continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million)
  • 31. Saudi Arabia continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million)

List of Figures

  • 1. Continuous glucose monitoring devices: Market segmentation
  • 2. Continuous glucose monitoring devices, 2013 - 2024 (USD Million)
  • 3. Continuous glucose monitoring devices market: Industry trend analysis
  • 4. Continuous glucose monitoring devices market: PESTEL analysis
  • 5. Continuous glucose monitoring devices market: Porter's analysis
  • 6. Continuous glucose monitoring devices company market share, 2015
  • 7. Key Opportunities Prioritized
  • 8. Continuous glucose monitoring devices market revenue share by product, 2016 & 2024
  • 9. Transmitters and receivers market revenue, 2013 to 2024 (USD Million)
  • 10. Sensors market revenue, 2013 to 2024 (USD Million)
  • 11. Insulin pumps market revenue, 2013 to 2024 (USD Million)
  • 12. Continuous glucose monitoring devices market revenue share end user, 2016 & 2024
  • 13. Hospital market revenue, 2013 to 2024 (USD Million)
  • 14. Homecare Diagnostics market revenue, 2013 to 2024 (USD Million)
  • 15. Diagnostic Centers market revenue, 2013 to 2024 (USD Million)
  • 16. Others market revenue, 2013 to 2024 (USD Million)
  • 17. Continuous glucose monitoring devices market share, by region, 2016 & 2024

The global continuous glucose monitoring (CGM) devices market size is expected to reach USD 1.01 billion by 2024, according to a new report by Grand View Research, Inc. The market is estimated to register a CAGR of 13.7% over the forecast period. Growing cases of diabetes and introduction of novel and advanced diabetes care devices are the major factors driving the market growth. Continuous glucose monitoring devices provide an efficient method to measure body glucose levels in real time. Data recorded by these devices is transmitted through a wireless network to receivers; this helps keep a track of glucose levels over a designated period.

These devices also help manage diabetes while reducing individual insulin dosages. Integrated software within these devices provides users with insights about food consumption, medication, physical activity, and illnesses. Thus, an increasing number of diabetic patients are using these devices to manage and treat diabetes, which, in turn, is accelerating market growth. With the advent of digital therapeutics, a rising number of CGM devices are being incorporated with apps and software to help patients with diabetes mellitus. Rise in the number of diabetes mellitus has been contributing toward market growth.

Further key findings from the study suggest:

  • Growing cases of diabetes is anticipated to propel market growth, with increasing number of patients opting for simplified CGM devices
  • CGM devices provide analysis of blood glucose levels from the tissue fluid at regular intervals of time, which is also driving their demand
  • Transmitters and receivers was the largest component type segment and is anticipated to maintain its dominance owing to their integral nature in these devices
  • Insulin pumps are anticipated to witness the highest CAGR during the forecast period due to their ability to maintain optimal blood glucose levels
  • Asia Pacific is the leading regional market, with Japan, China, and India on the forefront
  • North America led the global market in the past owing to wide usage of CGM devices as a result of higher number of target patients in the region
  • The European region followed the North American closely in terms of market revenue due to rise in the adoption of these devices in key countries such as U.K., Germany, France, Italy, and Spain

Some of the key companies present in the market are: Pfizer Inc.; Baxter International, Inc.; Abbott Laboratories; Medtronic PLC; Animas Corporation; and Novo Nordisk A/S.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Research scope & assumption
  • 1.3. List of data sources

Chapter 2. Executive Summary

  • 2.1. Continuous Glucose Monitoring Devices Market - Industry Summary and Key Buying Criteria, 2013 - 2024

Chapter 3. Continuous Glucose Monitoring Devices Industry Outlook

  • 3.1. Market segmentation
  • 3.2. Market size and growth prospects, 2013 - 2024
  • 3.3. Continuous Glucose Monitoring Devices: Market dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increasing number of diabetes patients globally
      • 3.3.1.2. Easy and efficient monitoring of current glucose values
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. High surge in the price and cost of treatment
  • 3.4. Continuous Glucose Monitoring Devices Market: Industry trend analysis
  • 3.5. Continuous Glucose Monitoring Devices Market: PESTEL Analysis
  • 3.6. Continuous Glucose Monitoring Devices Industry Analysis - Porter's Five Forces Model
  • 3.7. Continuous Glucose Monitoring Devices: Company market share analysis (%), 2015
  • 3.8. Key opportunities prioritized

Chapter 4. Continuous Glucose Marketing Product Outlook

  • 4.1. Continuous Glucose Monitoring Revenue Share (%) Analysis, by Product, 2016 & 2024
  • 4.2. Transmitters and Receivers
    • 4.2.1. Transmitters and receivers market revenue, by region, 2013 to 2024 (USD Million)
  • 4.3. Sensors
    • 4.3.1. Sensors market revenue, by region, 2013 to 2024 (USD Million)
  • 4.4. Insulin Pumps
    • 4.4.1. Insulin pumps market revenue, by region, 2013 to 2024 (USD Million)

Chapter 5. Continuous Glucose Monitoring end - user Outlook

  • 5.1. Continuous Glucose Monitoring Revenue Share (%) Analysis, by end - user, 2016 & 2024
  • 5.2. Hospital
    • 5.2.1. Hospital market revenue, by region, 2013 to 2024 (USD Million)
  • 5.3. Homecare Diagnostics
    • 5.3.1. Homecare diagnostics market revenue, by region, 2013 to 2024 (USD Million)
  • 5.4. Others
    • 5.4.1. Others market revenue, by region, 2013 to 2024 (USD Million)

Chapter 6. Continuous Glucose Monitoring Regional Outlook

  • 6.1. Continuous Glucose Monitoring Market Share (%) Analysis, by Region, 2014 & 2024
  • 6.2. North America
    • 6.2.1. U.S.
      • 6.2.1.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.2.1.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
    • 6.2.2. Canada
      • 6.2.2.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.2.2.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
  • 6.3. Europe
    • 6.3.1. Germany
      • 6.3.1.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.3.1.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
    • 6.3.2. U.K.
      • 6.3.2.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.3.2.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. China
      • 6.4.1.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.4.1.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
    • 6.4.2. India
      • 6.4.2.1.continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.4.2.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
  • 6.5. MEA
    • 6.5.1. South Africa
      • 6.5.1.1. continuous glucose monitoring devices market, by product application, 2013 - 2024 (USD Million)
      • 6.5.1.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
    • 6.5.2. Saudi Arabia
      • 6.5.2.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.5.2.2. continuous glucose monitoring devices market, by end - user application, 2013 - 2024 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.6.1.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
      • 6.6.2.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Roche Diagnostics
    • 7.1.1. Company Overview
    • 7.1.2. Financial Performance
    • 7.1.3. Product Benchmarking
    • 7.1.4. Strategic Initiatives
  • 7.2. Dexcom Inc.
    • 7.2.1. Company Overview
    • 7.2.2. Financial Performance
    • 7.2.3. Product Benchmarking
    • 7.2.4. Strategic Initiatives
  • 7.3. Abbott Laboratories
    • 7.3.1. Company Overview
    • 7.3.2. Financial Performance
    • 7.3.3. Product Benchmarking
    • 7.3.4. Strategic Initiatives
  • 7.4. Medtronic Inc.
    • 7.4.1. Company Overview
    • 7.4.2. Financial Performance
    • 7.4.3. Product Benchmarking
    • 7.4.4. Strategic Initiatives
  • 7.5. Animas Corporation
    • 7.5.1 Company Overview
    • 7.5.2 Financial Performance
    • 7.5.3 Product Benchmarking
    • 7.5.4 Strategic Initiatives
  • 7.6. Novo Nordisk
    • 7.6.1. Company Overview
    • 7.6.2. Financial Performance
    • 7.6.3. Product Benchmarking
    • 7.6.4. Strategic Initiatives
  • 7.7. Ypsomed AG
    • 7.7.1. Company Overview
    • 7.7.2. Financial Performance
    • 7.7.3. Product Benchmarking
    • 7.7.4. Strategic Initiatives
  • 7.8. GlySens Incorporated
    • 7.8.1. Company Overview
    • 7.8.2. Financial Performance
    • 7.8.3. Product Benchmarking
    • 7.8.4. Strategic Initiatives
Back to Top
전화 문의
F A Q